EAST-LC: Randomized Controlled Phase III Trial of S-1 Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Who Had Received a Platinum-Based Treatment

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdw383.18

Related search